55 - 74岁女性酒精摄入与乳腺癌的组织学亚型和雌激素受体状况的关系

IF 3 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology
Hormones & Cancer Pub Date : 2017-08-01 Epub Date: 2017-05-31 DOI:10.1007/s12672-017-0297-2
Michelle L Baglia, Kathleen E Malone, Mei-Tzu C Tang, Christopher I Li
{"title":"55 - 74岁女性酒精摄入与乳腺癌的组织学亚型和雌激素受体状况的关系","authors":"Michelle L Baglia,&nbsp;Kathleen E Malone,&nbsp;Mei-Tzu C Tang,&nbsp;Christopher I Li","doi":"10.1007/s12672-017-0297-2","DOIUrl":null,"url":null,"abstract":"<p><p>Previous studies suggest that alcohol consumption and risk of breast cancer may differ by histologic subtype and hormone receptor status, though results are not entirely consistent. In this population-based case-control study, we evaluated the association between alcohol consumption and risk of invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and invasive ductal-lobular carcinoma (IDLC) overall and by estrogen receptor (ER) status, among women aged 55-74 years of age. Using polytomous regression, associations between current alcohol consumption, overall and by type of alcohol, and breast cancer risk were evaluated in 891 controls and 905 IDC, 567 ILC, and 489 IDLC cases. Current alcohol use was moderately associated with risk of ILC (odds ratio = 1.25, 95% confidence interval 0.99, 1.58) with a positive dose-response relationship based on average number of drinks per week consumed (P <sub>trend</sub> = 0.0005). When further stratified by ER status, alcohol use was positively associated with risk of ER+ ILC (P <sub>trend</sub> = 0.002) and ER+ IDC (P <sub>trend</sub> = 0.02), but inversely associated with risk of ER-IDC (P <sub>trend</sub> = 0.01). No association between alcohol and risk of IDLC tumors was observed. While the link between alcohol consumption and breast cancer risk is well established, our results suggest that the increased risk associated with alcohol is largely limited to ER+ ILC and ER+ IDC. Thus, avoiding or moderating alcohol consumption may be one way that women can lower their risks of these forms of breast cancer.</p>","PeriodicalId":13060,"journal":{"name":"Hormones & Cancer","volume":" ","pages":"211-218"},"PeriodicalIF":3.0000,"publicationDate":"2017-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s12672-017-0297-2","citationCount":"7","resultStr":"{\"title\":\"Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years.\",\"authors\":\"Michelle L Baglia,&nbsp;Kathleen E Malone,&nbsp;Mei-Tzu C Tang,&nbsp;Christopher I Li\",\"doi\":\"10.1007/s12672-017-0297-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Previous studies suggest that alcohol consumption and risk of breast cancer may differ by histologic subtype and hormone receptor status, though results are not entirely consistent. In this population-based case-control study, we evaluated the association between alcohol consumption and risk of invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and invasive ductal-lobular carcinoma (IDLC) overall and by estrogen receptor (ER) status, among women aged 55-74 years of age. Using polytomous regression, associations between current alcohol consumption, overall and by type of alcohol, and breast cancer risk were evaluated in 891 controls and 905 IDC, 567 ILC, and 489 IDLC cases. Current alcohol use was moderately associated with risk of ILC (odds ratio = 1.25, 95% confidence interval 0.99, 1.58) with a positive dose-response relationship based on average number of drinks per week consumed (P <sub>trend</sub> = 0.0005). When further stratified by ER status, alcohol use was positively associated with risk of ER+ ILC (P <sub>trend</sub> = 0.002) and ER+ IDC (P <sub>trend</sub> = 0.02), but inversely associated with risk of ER-IDC (P <sub>trend</sub> = 0.01). No association between alcohol and risk of IDLC tumors was observed. While the link between alcohol consumption and breast cancer risk is well established, our results suggest that the increased risk associated with alcohol is largely limited to ER+ ILC and ER+ IDC. Thus, avoiding or moderating alcohol consumption may be one way that women can lower their risks of these forms of breast cancer.</p>\",\"PeriodicalId\":13060,\"journal\":{\"name\":\"Hormones & Cancer\",\"volume\":\" \",\"pages\":\"211-218\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2017-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s12672-017-0297-2\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hormones & Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12672-017-0297-2\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/5/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormones & Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12672-017-0297-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/5/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 7

摘要

先前的研究表明,饮酒和乳腺癌的风险可能因组织学亚型和激素受体状态而异,尽管结果并不完全一致。在这项以人群为基础的病例对照研究中,我们评估了饮酒与浸润性导管癌(IDC)、浸润性小叶癌(ILC)和浸润性导管小叶癌(IDLC)风险之间的关系,并通过雌激素受体(ER)状态对年龄在55-74岁的女性进行了评估。采用多元回归法,对891例对照、905例IDC、567例ILC和489例IDLC患者的当前饮酒量、总体饮酒量和按酒精类型分类的饮酒量与乳腺癌风险之间的关系进行了评估。当前饮酒与ILC风险中度相关(优势比= 1.25,95%可信区间0.99,1.58),且基于每周平均饮酒量的正剂量反应关系(P趋势= 0.0005)。进一步按ER状态分层,酒精使用与ER+ ILC (P趋势= 0.002)和ER+ IDC (P趋势= 0.02)呈正相关,与ER-IDC (P趋势= 0.01)呈负相关。未观察到酒精与IDLC肿瘤风险之间的关联。虽然饮酒与乳腺癌风险之间的联系已经确立,但我们的研究结果表明,与酒精相关的风险增加在很大程度上仅限于ER+ ILC和ER+ IDC。因此,避免或减少饮酒可能是女性降低患这些类型乳腺癌风险的一种方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years.

Previous studies suggest that alcohol consumption and risk of breast cancer may differ by histologic subtype and hormone receptor status, though results are not entirely consistent. In this population-based case-control study, we evaluated the association between alcohol consumption and risk of invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and invasive ductal-lobular carcinoma (IDLC) overall and by estrogen receptor (ER) status, among women aged 55-74 years of age. Using polytomous regression, associations between current alcohol consumption, overall and by type of alcohol, and breast cancer risk were evaluated in 891 controls and 905 IDC, 567 ILC, and 489 IDLC cases. Current alcohol use was moderately associated with risk of ILC (odds ratio = 1.25, 95% confidence interval 0.99, 1.58) with a positive dose-response relationship based on average number of drinks per week consumed (P trend = 0.0005). When further stratified by ER status, alcohol use was positively associated with risk of ER+ ILC (P trend = 0.002) and ER+ IDC (P trend = 0.02), but inversely associated with risk of ER-IDC (P trend = 0.01). No association between alcohol and risk of IDLC tumors was observed. While the link between alcohol consumption and breast cancer risk is well established, our results suggest that the increased risk associated with alcohol is largely limited to ER+ ILC and ER+ IDC. Thus, avoiding or moderating alcohol consumption may be one way that women can lower their risks of these forms of breast cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Hormones & Cancer
Hormones & Cancer ONCOLOGY-ENDOCRINOLOGY & METABOLISM
CiteScore
4.60
自引率
0.00%
发文量
0
期刊介绍: Hormones and Cancer is a unique multidisciplinary translational journal featuring basic science, pre-clinical, epidemiological, and clinical research papers. It covers all aspects of the interface of Endocrinology and Oncology. Thus, the journal covers two main areas of research: Endocrine tumors (benign & malignant tumors of hormone secreting endocrine organs) and the effects of hormones on any type of tumor. We welcome all types of studies related to these fields, but our particular attention is on translational aspects of research. In addition to basic, pre-clinical, and epidemiological studies, we encourage submission of clinical studies including those that comprise small series of tumors in rare endocrine neoplasias and/or negative or confirmatory results provided that they significantly enhance our understanding of endocrine aspects of oncology. The journal does not publish case studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信